ESHRE 2022 Main programme


Please take the 
time zone differences into account! Times are shown in CET – Central European Time.                                                                     
>> Monday >> Tuesday >> Wednesday




Monday 04 July 2022

08:30 - 09:30
Invited session 01: Keynote Session
08:30 - 09:00
Human reproduction Keynote lecture
Speaker to be announced
09:00 - 09:30
Truths and fallacies of treatment personalisation in reproductive medicine
Efstratios Kolibianakis, Greece

09:30 - 10:00
Coffee break

10:00 - 11:30
6 Parallel selected oral communications sessions

11:45 - 13:00
Industry Sponsored symposium

11:45 - 12:45
Invited session 02: A deeper understanding of fertilisation
12:45 - 13:15
Novel sperm centrosome function, structure, and composition during fertilization
Tomer Avidor-Reiss, U.S.A.
12:15 - 12:45
An unorthodox tale for the first embryonic mitosis
Jan Ellenberg, Germany

11:45 - 12:45
Invited session 03: Data reporting session

11:45 - 12:45
Invited session 04: Exchange session

11:45 - 12:45
Invited session 05: Optimising oocyte yield
11:45 - 12:15
Can ovarian response be predicted and why would you want to know?
Bart C.J.M. Fauser, The Netherlands
12:15 - 12:45
The optimal gonadotrophin dose in art
Ying Cheong, United Kingdom

13:00 - 14:00
Lunch Break

14:00 - 15:15
Industry sponsored symposium

14:00 - 15:00
Invited session 06: Horizon scanning on Male Fertility
14:00 - 14:30
The male reproductive health initiative - global collaboration and progress update
Christopher De Jonge, U.S.A.
14:30 - 15:00
Male fertility testing - new horizons, ideas and research
Albert Salas-Huetos, U.S.A.

14:00 - 15:00
Invited session 07: Safe treatments in unsafe times – lessons learned from COVID-19
14:00 - 14:30
ART treatment and pregnancy during covid 19 pandemia: what we learned
Anna Veiga, Spain
14:30 - 15:00
COVID-19 during pregnancy, maternal immune response and neonatal cell-specific immunity
Petra Arck, Germany

14:00 - 15:00
Invited session 08: Refusing treatment: when can or should treatment be denied?
14:00 - 14:30
Treatment can only be denied in very exceptional circumstances
Nicola Williams, United Kingdom
14:30 - 15:00
The duty to do no harm implies that some requests for treatment should be denied
Speaker to be confirmed

14:00 - 15:00
Selected oral communications session

15:15 - 16:30
6 Parallel selected oral communication sessions

16:30 - 17:00
Coffee break

17:00 - 18:15
Industry sponsored symposium

17:00 - 18:00
Invited session 09: Do you get cancer from endometriosis
17:00 - 17:30
Epidemiological viewpoint
Stacey Missmer, U.S.A.
17:30 - 18:00
Pathological/theoretical viewpoint
Paola Vigano, Italy

17:00 - 18:00
Invited session 10: New insights on our favorite chromosomes, the sex chromosomes
17:00 - 17:30
The persistent Y hypothesis
Paul. D Waters, Australia
17:30 - 18:00
The role of amnion and a human specific signaling centre in preimplantation development
Fredrick Lanner, Sweden

17:00 - 18:00
Invited session 11: A safe and effective lab: Design vs. functionality
17:00 - 17:30
Building the perfect cleanroom IVF lab and maintaining it
Ronny Janssens, Belgium
17:30 - 18:00
Changing the IVF lab in qualitative way: tips on how to handle infrastructural changes in the cleanroom IVF lab
Marc J.G. Van den Bergh, Switzerland

17:00 - 18:00
Selected oral communications session